Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Kavanaugh

Showing results (41-50 of 381) with videos related to

Pageof 39
Sort By:
Therapeutic Advances in Musculoskeletal Disease|September 14, 2018
The role of golimumab in inflammatory arthritis. A review of the evidenceZunera Tahir, Arthur Kavanaugh
Current Rheumatology Reports|May 28, 2005
Outcome measures in psoriatic arthritisArthur Kavanaugh, Sarah Cassell
Journal of Immune Based Therapies and Vaccines|September 6, 2005
Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatmentSarah Cassell, Arthur Kavanaugh
Therapeutics and Clinical Risk Management|February 12, 2009
Interleukin-6 inhibitors in the treatment of rheumatoid arthritisStephanie Hennigan, Arthur Kavanaugh
Current Opinion in Rheumatology|March 14, 2012
Patient-reported outcomes in rheumatoid arthritisMinyoung Her, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America|July 18, 2025
Challenges in Developing Treatment Guidelines in Psoriatic ArthritisLarabe Farrukh, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America|October 18, 2015
Novel Treatment Concepts in Psoriatic ArthritisTristan Boyd, Arthur Kavanaugh
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
Treatment of psoriatic arthritis with biological agentsArnold Ceponis, Arthur Kavanaugh
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
The clinical efficacy of tocilizumab in rheumatoid arthritisMaja Mircic, Arthur Kavanaugh
Expert Opinion on Drug Safety|April 2, 2015
Drug safety evaluation of apremilast for treating psoriatic arthritisSwapna Busa, Arthur Kavanaugh
Pageof 39

Showing results (41-50 of 381) with videos related to

Sort By:
Pageof 39
Therapeutic Advances in Musculoskeletal Disease|September 14, 2018
The role of golimumab in inflammatory arthritis. A review of the evidenceZunera Tahir, Arthur Kavanaugh
Current Rheumatology Reports|May 28, 2005
Outcome measures in psoriatic arthritisArthur Kavanaugh, Sarah Cassell
Journal of Immune Based Therapies and Vaccines|September 6, 2005
Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatmentSarah Cassell, Arthur Kavanaugh
Therapeutics and Clinical Risk Management|February 12, 2009
Interleukin-6 inhibitors in the treatment of rheumatoid arthritisStephanie Hennigan, Arthur Kavanaugh
Current Opinion in Rheumatology|March 14, 2012
Patient-reported outcomes in rheumatoid arthritisMinyoung Her, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America|July 18, 2025
Challenges in Developing Treatment Guidelines in Psoriatic ArthritisLarabe Farrukh, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America|October 18, 2015
Novel Treatment Concepts in Psoriatic ArthritisTristan Boyd, Arthur Kavanaugh
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
Treatment of psoriatic arthritis with biological agentsArnold Ceponis, Arthur Kavanaugh
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
The clinical efficacy of tocilizumab in rheumatoid arthritisMaja Mircic, Arthur Kavanaugh
Expert Opinion on Drug Safety|April 2, 2015
Drug safety evaluation of apremilast for treating psoriatic arthritisSwapna Busa, Arthur Kavanaugh
Pageof 39